ACORDA THERAPEUTICS, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f1364b39-ed80-40aa-8734-6c0bf2db41a0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-252.9M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-039464 |
| FY 2022 | $-65.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-007948 |
| FY 2021 | $-104.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010971 |
| FY 2020 | $-99.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013318 |
| FY 2019 | $-273.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007789 |
| FY 2018 | $33.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004986 |
| FY 2017 | $-223.4M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-003967 |
| FY 2016 | $-34.6M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002591 |
| FY 2015 | $11.1M | 2015-01-01 – 2015-12-31 | evidence 0001008848-16-000076 |
| FY 2014 | $17.7M | 2014-01-01 – 2014-12-31 | evidence 0001008848-15-000009 |
| FY 2013 | $16.4M | 2013-01-01 – 2013-12-31 | evidence 0001008848-14-000011 |
| FY 2012 | $155.0M | 2012-01-01 – 2012-12-31 | evidence 0001008848-13-000011 |
| FY 2011 | $30.6M | 2011-01-01 – 2011-12-31 | evidence 0001008848-12-000015 |
| FY 2010 | $-11.8M | 2010-01-01 – 2010-12-31 | evidence 0001008848-12-000015 |
| FY 2009 | $-83.9M | 2009-01-01 – 2009-12-31 | evidence 0001008848-12-000015 |
| FY 2008 | $-74.3M | 2008-01-01 – 2008-12-31 | evidence 0001008848-11-000018 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACORDA THERAPEUTICS, INC. — all facts · Revenue · Operating Income